Shuang Yang, Scientist, China

Shuang Yang, Scientist, China

Shuang Yang, Scientist, China

Second quarter 2024 results

Second quarter 2024 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

Our Latest Stories

Social Impact

July 18, 2024

Caring for Community & Planet: How Sanofi Is Improving Lives While Reducing Its Emissions

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

Sanofi X Paris 2024

We’re proud to be premium partner of Paris 2024.

Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.

About Us

Who We Are

We are an innovative global healthcare company.

Our Pipeline

5

Therapeutic areas

78

Compounds in clinical development

29

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases

July 25, 2024
Press Release: Online availability of Sanofi’s half-year financial report for 2024
July 25, 2024
Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
July 17, 2024
Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
July 3, 2024
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD